Agilon HealthAGL +0.27%74 EBITDA Margin % is 2.71% as of Mar. 2026. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.48 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Agilon Health ranks worse than 78.74% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Agilon Health's EBITDA for the
three
months ended in Mar. 2026 was $39 Mil. Agilon Health's Revenue for the
three
months ended in Mar. 2026 was $1,420 Mil. Therefore, Agilon Health's EBITDA margin for the quarter that ended in Mar. 2026 was 2.71%.
Agilon Health (NYSE:AGL) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Agilon Health EBITDA Margin % Related Terms
Agilon Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Agilon Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AGL vs AVAH, HCSG, SNDA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Agilon Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Agilon Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (AGL) has a EBITDA Margin % of 2.71% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Agilon Health and its competitors. According to the industry distribution chart, Agilon Health ranks #526 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 78.7%.
Is Agilon Health's EBITDA Margin % too high?
Agilon Health's current EBITDA Margin % is 2.71%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Agilon Health's value of 2.71% is 73.5% below this industry median. Based on the distribution chart, Agilon Health ranks #526 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's EBITDA Margin % compare to AVAH and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #526 out of 668 companies for EBITDA Margin %. This places Agilon Health in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Agilon Health's value of 2.71% is 73.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current EBITDA Margin % of 2.71% is 73.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current EBITDA Margin % is 2.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $107.25 — trading 13.5% above its estimated fair value. The current EBITDA Margin % is 2.71% and 73.5% below the Healthcare Providers & Services industry median of 10.21. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Agilon Health (AGL), the current EBITDA Margin % is 2.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $107.25 is trading 13.5% above its estimated GF Value™ of $94.48.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
EBITDA Margin %: 2.71%
GF Value™: $94.48 vs. price of $107.25 (13.5% above fair value)
Industry Position: 73.5% below the Healthcare Providers & Services median (#526 of 668)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score
Get the complete analysis for AGL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
